Insider filing · ELVN
J. Scott Garland
Director
profile →
Enliven Therapeutics, Inc.
ELVN · Healthcare · 56 filings in 24 months
ticker →
J. Scott Garland sold $607K of Enliven Therapeutics (ELVN)
Executed Oct 1, disclosed Oct 5, 4 days later.
Value, as filed
$607K
13,000 sh × $46.67
Executed
Oct 1
the trade date, as filed
Disclosed
Oct 5
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JGJ. Scott Garland (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $607K of ELVN (13,000 sh × $46.67, as filed), executed Oct 1.
The name
ELVNHealthcare · Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibito…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→